Skip to content
AnalystLens

ADM · Archer-Daniels-Midland

382 filings

ADM SEC Filings

Archer-Daniels-Midland - 382 total filings

Filing record · 2016–202610-K1210-Q368-K102

ADM filed 12 annual reports (10-K), 36 quarterly reports (10-Q) and 102 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’19Nov ’19
  2. Leadership change8-K · Nov ’22Nov ’22
  3. FY2024 annual report10-K · Feb ’25Feb ’25
Showing 1–50 of 382 filings
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Nov 3, 2026)

Archer-Daniels-Midland Company (ADM) reported its third quarter 2026 financial results, showcasing significant year-over-year improvements across its segments. The company's adjusted Earnings Per Share (EPS) reached $1.77, a substantial increase from the prior year. Driven by robust execution and a favorable biofuels environment, ADM has raised its full-year 2026 adjusted EPS guidance to a range of $5.50 to $5.80. The Ag Services & Oilseeds segment was a primary driver of this growth, with a 105% increase in operating profit, largely due to strong North American biofuels margins influenced by favorable policy and higher energy prices. Carbohydrate Solutions also demonstrated solid performance with a 40% increase in operating profit, supported by healthy ethanol margins. While the Nutrition segment saw modest growth, overall company performance indicates strong operational momentum and effective strategy execution in a constructive market environment. ADM also managed to reduce its projected capital expenditures for the year, focusing on high-return investments.

Nov 3, 2026
10-Q

Archer-Daniels-Midland Quarterly Report for Q3 Ended Sep 30, 2026

Archer-Daniels-Midland Company (ADM) reported a significant increase in financial performance for the nine months ended September 30, 2026, compared to the same period in 2025. Earnings Before Income Taxes surged from $779 million to $2.5 billion, driven by improved operational execution across all segments, particularly Ag Services and Oilseeds and Carbohydrate Solutions. This growth was fueled by a constructive pricing environment, supportive policy incentives, and benefits from renewable fuel economics. The company also saw a substantial increase in total segment operating profit, rising from $2.4 billion to $3.6 billion, reflecting strong performance in its core business segments. Revenues grew by $3.8 billion, primarily due to higher sales prices in the Ag Services and Oilseeds segment and increased sales in the Carbohydrate Solutions segment. ADM continues to focus on improving manufacturing costs, reducing transaction costs through digitalization, and investing in high-growth opportunities in nutrition and biosolutions.

Nov 3, 2026
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (Aug 12, 2026)

Archer-Daniels-Midland Co (ADM) announced on August 12, 2026, that Lei Z. Schlitz will be resigning from her position as a director on the Board, effective December 31, 2026. This decision stems from a voluntary material change in her principal employment. Ms. Schlitz's departure is amicable and is not attributed to any disagreements regarding the Company's operations, policies, or practices. The Board has expressed gratitude for her contributions and service.

Aug 12, 2026
8-K

Archer-Daniels-Midland 8-K Report, Exhibit Filing (Aug 10, 2026)

Archer-Daniels-Midland Company (ADM) has filed an 8-K report on August 10, 2026, primarily to disclose details regarding the issuance of new debt. The company successfully raised $1 billion through the sale of two series of notes: $500 million in 4.829% Notes due 2031 and $500 million in 5.269% Notes due 2036. This filing is in conjunction with a previously filed Registration Statement on Form S-3, indicating a public offering of these securities. The primary focus for investors in this filing is the company's capital structure management and its cost of debt. The issuance of these notes represents a significant capital raise, which could be used for various corporate purposes such as funding operations, strategic investments, acquisitions, or refinancing existing debt. The specific interest rates on the notes provide insight into ADM's current borrowing costs and market conditions at the time of issuance.

Aug 10, 2026
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Aug 4, 2026)

ADM reported strong second-quarter 2026 results, with GAAP EPS of $1.87 (versus $0.45 a year ago) and adjusted EPS of $1.84 (versus $0.93), on total segment operating profit of $1.45 billion, up 75% year over year. Growth was broad-based across all three segments. Ag Services & Oilseeds rose 129% to $867 million, driven by crushing margins and a RVO-supported biofuels environment, while Carbohydrate Solutions rose 22% to $411 million on higher ethanol margins and policy incentives. Nutrition rose 51% to $172 million, led by Flavors and Decatur East progress. Year-to-date, adjusted EPS was $2.56, up 57%. Roughly $100 million of the AS&O quarter benefited from net positive mark-to-market and timing effects, so part of the quarter's strength is not expected to repeat as operating earnings. Management raised 2026 adjusted EPS guidance to approximately $5.15 to $5.60, up from $4.15 to $4.70, citing the finalized 2026 and 2027 Renewable Volume Obligations, elevated energy prices, and continued Nutrition momentum. Capital expenditure guidance of $1.3 to $1.5 billion was reiterated. The guidance excludes GAAP EPS reconciliation because of uncertainty around impairments, restructuring, and other reconciling items. Cash flow was weaker than earnings: operating cash flow for the first half was $1.3 billion versus $4.0 billion a year earlier, driven by a $460 million working capital outflow, though the company still paid $510 million in dividends. The key investor considerations are the durability of biofuels-driven margins, which depend on policy and energy prices, the quality of earnings given mark-to-market benefits, and whether working capital normalizes. Equity earnings from Wilmar fell 22% in the quarter, and the company continues to flag macroeconomic, trade, and policy risks.

Aug 4, 2026
10-Q

Archer-Daniels-Midland Quarterly Report for Q2 Ended Jun 30, 2026

Archer-Daniels-Midland Company (ADM) reported robust financial results for the three and six months ended June 30, 2026. The company demonstrated significant year-over-year improvements in earnings before income taxes, primarily driven by enhanced operational execution and a more favorable pricing environment. Revenue growth was substantial, fueled by strong performance in the Ag Services and Oilseeds segment, which benefited from higher sales prices for key commodities and improved crush volumes. ADM's profitability was bolstered by increased gross profit across all its reportable segments, particularly Ag Services and Oilseeds and Carbohydrate Solutions. Despite an increase in Selling, General, and Administrative (SG&A) expenses, the company managed to reduce asset impairment, exit, and restructuring costs compared to the prior year. This operational strength, coupled with favorable market conditions and strategic initiatives like the Clean Fuel Production Credit (Section 45Z) and the Renewable Volume Obligations (RVO), positions ADM for continued growth. Investors should note the company's ongoing focus on cost optimization, digitalization, and investments in high-growth areas within nutrition and biosolutions.

Aug 4, 2026
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (Jul 23, 2026)

ADM filed an 8-K reporting the appointment of Jeff Rowe as Executive Vice President and Chief Operating Officer, effective August 17, 2026, announced July 20, 2026. Rowe is currently CEO of Syngenta Group (since January 2024) and steps down from that role August 1, 2026. Per the press release, the COO role is newly created and oversees ADM's commercial businesses, global manufacturing, and R&D, reporting directly to Chair and CEO Juan Luciano. The filing contains no financial results, guidance, or other operating metrics, so the event is primarily a leadership and governance update. The compensation package is substantial and signals ADM's intent to secure Rowe quickly. It includes a $1.2 million base salary, a 175% target annual cash incentive (pro-rated for 2026), a $12.5 million annual target equity opportunity, and a 2026 equity grant with a $11.1 million grant-date value (60% PSUs, 40% RSUs). To offset forfeited awards from Syngenta, ADM is providing a one-time $2.2 million cash bonus payable January 2027 and $16.69 million in RSUs vesting 40% at five months and 60% at 17 months. Relocation benefits and standard executive benefits are also included. The make-whole awards total roughly $18.9 million, which is a near-term cost, though the sizing is typical for an external senior hire. For investors, the key questions are execution and strategic direction. Rowe brings a deep agricultural science and seed/crop protection background, which fits ADM's agricultural supply chain and nutrition businesses. Because the role consolidates commercial, manufacturing, and R&D oversight, it may signal an effort to tighten operational execution. The filing does not provide details on specific strategic changes, so the market impact will depend on how the role is defined and what results follow.

Jul 23, 2026
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (May 12, 2026)

Archer-Daniels-Midland Company (ADM) filed an 8-K report on May 12, 2026, detailing the outcomes of its 2026 Annual Meeting of Stockholders held on May 7, 2026. The key event was the approval by stockholders of an amendment to the 2020 Incentive Compensation Plan (2020 IC Plan), which increases the shares available for awards by 9,000,000. This move is aimed at ensuring the company can continue to attract and retain talent through equity-based compensation. Beyond the incentive plan amendment, the meeting also saw the election of all nominated directors to the Board, the advisory approval of the compensation of named executive officers, and the ratification of Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2026. A stockholder proposal regarding pesticide use data reporting in regenerative agriculture disclosures was not approved.

May 12, 2026
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (May 5, 2026)

ADM reported first-quarter 2026 GAAP EPS of $0.62 (up about 2% year over year) and adjusted EPS of $0.71 (up about 1%), with net earnings attributable to ADM of $298 million. Headline results were roughly flat, but the segment mix shifted sharply. Results absorbed roughly $275 million of net negative mark-to-market and timing impacts, concentrated in Crushing (about 70%), as commodity and margin prices strengthened after U.S. biofuels policy clarity. Ag Services & Oilseeds segment operating profit fell 34% to $273 million, while Carbohydrate Solutions rose 48% to $356 million on stronger ethanol margins, with Vantage Corn Processors up $94 million. Nutrition rose 42% to $135 million, led by Human Nutrition and Animal Nutrition improvements. The most important forward-looking item is the guidance raise. ADM now expects 2026 adjusted EPS of $4.15 to $4.70, up from $3.60 to $4.25, which management attributes to the finalization of the 2026 and 2027 Renewable Volume Obligations under the U.S. Renewable Fuels Standard in March 2026. Management expects the improvement mainly in crushing and ethanol. Capital expenditures are still projected at $1.3 to $1.5 billion. The guidance excludes forecasted GAAP EPS because of uncertainty around impairments, restructuring, and other reconciling items. Quality of earnings is a point for investors to weigh. Adjusted net earnings of $345 million excluded a $62 million gain on asset contributions tied to new joint ventures, a $55 million charge from ADM's share of Wilmar provisions, and other specified items. Operating cash flow was $150 million, compared with negative $342 million a year earlier, mainly due to smaller working capital outflows. Adjusted ROIC was 6.4%, and net debt-related liabilities declined year over year, with short-term debt down to $1.72 billion from $2.77 billion.

May 5, 2026
10-Q

Archer-Daniels-Midland Quarterly Report for Q1 Ended Mar 31, 2026

Archer-Daniels-Midland Co. (ADM) reported solid financial results for the first quarter of 2026, with revenues reaching $20.49 billion, a slight increase from $20.18 billion in the same period last year. Net earnings attributable to ADM were $298 million, or $0.62 per diluted share, showing modest growth from the prior year's $295 million, or $0.61 per diluted share. The company demonstrated improved profitability in its Carbohydrate Solutions and Nutrition segments, although the Ag Services and Oilseeds segment experienced a decline in operating profit due to negative mark-to-market and timing impacts. Despite these fluctuations, ADM's overall performance indicates resilience and continued strategic execution in a dynamic market environment.

May 5, 2026
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (Mar 10, 2026)

Archer-Daniels-Midland Co (ADM) filed an 8-K on March 10, 2026 reporting a routine board change. On March 9, 2026, the Board increased its size from 12 to 13 directors and appointed Michael C. McMurray as an independent director, effective immediately, to fill the newly created seat. He was placed on the Audit Committee and the Sustainability and Technology Committee and will serve until the next annual meeting. The filing states there are no arrangements or related person transactions involving him, and his director compensation will follow the company's existing non-employee director policy as described in the 2025 proxy statement. McMurray brings substantial financial and industrial credentials. He most recently served more than five years as executive vice president and CFO of LyondellBasell Industries N.V., and previously held CFO and other leadership roles at Owens Corning and roles at Royal Dutch Shell. Board Chair and CEO Juan Luciano framed the appointment as part of an ongoing board refreshment practice, emphasizing financial and accounting expertise, international experience, and strategy and M&A leadership. The appointment is a governance step rather than a financial event, and the filing contains no financial results, guidance, or material transaction disclosures. For investors, the significance lies mainly in board composition. Adding a former public-company CFO to the Audit Committee may strengthen financial oversight, and the expanded board suggests continued refreshment as ADM pursues its growth strategy. The filing does not indicate any change to ADM's operations, capital allocation, or outlook, so investors should view this as a low-impact governance update.

Mar 10, 2026
10-K

Archer-Daniels-Midland Annual Report, Year Ended Dec 31, 2025

Archer-Daniels-Midland Company (ADM) reported a challenging year for the fiscal year ending December 31, 2025. While revenues saw a decrease of $5.3 billion to $80.3 billion, driven by lower sales volumes and prices across segments, the company's focus remains on strategic priorities including operational excellence, cost management, and targeted growth investments. The Ag Services and Oilseeds segment experienced compressed margins due to increased global supplies, policy uncertainties, and logistical issues, leading to a significant decline in segment operating profit. The Carbohydrate Solutions segment also saw a decrease in operating profit, influenced by lower ethanol and starch margins and higher manufacturing costs. However, the Nutrition segment demonstrated resilience, with a modest increase in segment operating profit, driven by growth in the Flavors market and expansion opportunities in dietary supplements, despite facing challenges from tariffs and inflation. ADM is actively pursuing cost savings, targeting over $500 million in cumulative savings over the next three to five years through cost optimization and portfolio simplification. The company made several strategic portfolio actions in 2025, including acquisitions and the formation of joint ventures to enhance its market position. Despite a decrease in earnings before income taxes by 44% year-over-year, largely due to significant impairment charges and equity method investment impacts, ADM maintains a strong liquidity position with $10.4 billion in total available liquidity. The company reiterated its commitment to disciplined capital deployment, including dividends, and is investing in future growth areas such as enhanced nutrition, biotics, and biosolutions.

Feb 17, 2026
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Feb 3, 2026)

ADM reported fourth-quarter and full-year 2025 results that reflected a difficult operating environment, driven by weak crush margins, muted global trade flows, and ongoing uncertainty around U.S. biofuel policy. Fourth-quarter GAAP EPS was $0.94 (down 20% YoY) and adjusted EPS was $0.87 (down 24%), while total segment operating profit fell 22% to $821 million. For full-year 2025, GAAP EPS was $2.23 (down 39%), adjusted EPS was $3.43 (down 28%), and total segment operating profit declined 23% to $3.2 billion. The decline was concentrated in Ag Services & Oilseeds, where Crushing profit fell 81% for the year, while Nutrition was the only segment to grow, rising 8%. Operating cash flow was strong at $5.5 billion, though much of that was driven by a $2.8 billion working capital release rather than underlying earnings (cash flow before working capital was $2.7 billion). For 2026, ADM guided to adjusted EPS of approximately $3.60 to $4.25, with the lower end assuming continued U.S. biofuel policy deferral and flat crush margins, and the upper end assuming crush margin expansion, manufacturing efficiency gains, and stronger customer demand. Management explicitly tied the position within that range to the timing of U.S. biofuel policy clarity, so investors should treat policy developments as the key swing factor. Capital expenditures are projected at $1.3 to $1.5 billion. The company also raised its quarterly dividend 2% to 52.0 cents, extending its streak to 53 consecutive years of dividend growth, while continuing to target $500 to $750 million in aggregate cost savings over three to five years. Quality-of-earnings considerations matter here. Fourth-quarter GAAP results were flattered by a $254 million non-cash gain from ADM's share of a Wilmar transaction, which was largely offset by $293 million of impairment, exit, and restructuring charges, and the non-GAAP measures exclude these items. Full-year adjusted results exclude $236 million of net specified charges, and ADM's Decatur-related insurance proceeds declined sharply year over year. Investors should weigh the adjusted figures against the GAAP results and recognize that the company did not provide a GAAP EPS forecast, citing the unreasonable efforts exemption.

Feb 3, 2026
8-K

Archer-Daniels-Midland 8-K Report, Corporate Update (Jan 28, 2026)

Archer-Daniels-Midland (ADM) has resolved its long-running investigations by the U.S. Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) relating to intersegment sales between its Nutrition segment and its Agriculture Services & Oilseeds and Carbohydrate Solutions segments. On January 27, 2026, ADM announced a settlement with the SEC under which it, without admitting or denying wrongdoing, will pay a $40 million civil penalty and agree to cease and desist from future violations of specified federal securities laws. The company states the amount is not expected to have a material adverse effect on its results of operations or financial position. Separately, the DOJ notified ADM that it is no longer a subject of its investigation and has closed the matter with no further action. For investors, the key takeaway is that the regulatory overhang tied to ADM's prior segment reporting has been removed. The filing indicates the underlying issues affected segment-level reporting only. According to the company, they had no impact on reported consolidated balance sheet, earnings, or cash flows for the periods presented in the restated filings. ADM previously corrected prior-period errors in March 2024 and restated its 2023 Form 10-K and the first and second quarter 2024 Forms 10-Q in November 2024. The company also notes that it has made significant changes to its financial leadership team and financial controls. The settlement's cease-and-desist terms are notable because they cover reporting and internal-controls provisions (Exchange Act Sections 13(a) and 13(b)(2)), which signals regulators' focus on the accuracy of periodic reporting going forward. Investors should weigh the closure of the enforcement matters against the continued need to monitor the effectiveness of ADM's remediated controls and segment disclosures, though the filing itself does not disclose any new financial results or guidance.

Jan 28, 2026
10-Q

Archer-Daniels-Midland Quarterly Report for Q3 Ended Sep 30, 2025

Archer-Daniels-Midland Co. (ADM) reported mixed financial results for the third quarter of fiscal year 2025. While revenues saw a modest increase driven by higher sales prices and volumes, particularly in the Ag Services and Oilseeds segment, gross profit experienced a decline due to compressed margins across key segments. The company incurred significant impairment and restructuring charges, including a substantial charge related to internal-use software and a penalty from an equity investment, which impacted net earnings. Despite these challenges, ADM generated strong operating cash flow and maintained substantial liquidity. The company's strategic focus remains on operational execution, cost management, portfolio simplification, and disciplined capital deployment. Recent portfolio actions include an acquisition in Hungary and the formation of a joint venture in animal feed. ADM is also actively cooperating with ongoing SEC and DOJ investigations, which have previously led to a material weakness in internal controls over financial reporting that has since been remediated.

Nov 4, 2025
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Nov 4, 2025)

ADM reported third-quarter 2025 GAAP earnings before income taxes of $147 million and GAAP diluted EPS of $0.22, versus $0.04 a year earlier, but the headline is weaker on an underlying basis. Adjusted EPS was $0.92, down 16% from $1.09, and total segment operating profit fell 19% to $845 million. The GAAP improvement was driven by $220 million of specified items, mainly portfolio optimization and impairment charges plus ADM's $163 million share of a penalty imposed on Wilmar, which the company excludes from adjusted results. Year-to-date, adjusted EPS of $2.56 is down 29% and segment operating profit of $2,422 million is down 23%, with Ag Services and Oilseeds (down 35%) the main drag, particularly Crushing (down 85% YTD). The most consequential news is guidance. ADM cut full-year 2025 adjusted EPS guidance to $3.25-$3.50 from approximately $4.00, citing lower crush margins tied to delayed U.S. biofuel policy and disrupted international trade flows. Management is pinning its 2026 outlook on expected clarity on biofuel policy and global trade. Cash generation was a relative bright spot: year-to-date operating cash flow reached $5.8 billion, helped by a $3.7 billion working capital release, and net debt fell substantially, with short-term debt down to $246 million and long-term debt at $7.6 billion. Shareholder equity was $22.5 billion. Investors should note that ADM did not provide a GAAP reconciliation for its forward guidance, citing the unreasonable efforts exemption because impairments, restructuring charges, and legal and tax outcomes are hard to predict. Nutrition was the clear positive, with segment operating profit up 24% in the quarter, and Carbohydrate Solutions remained steady sequentially. The overall message is a company in a cyclical trough that is cutting costs, optimizing its portfolio, and generating cash, but still dependent on policy outcomes for a meaningful earnings recovery.

Nov 4, 2025
8-K

Archer-Daniels-Midland 8-K Report, Regulation FD Disclosure (Sep 23, 2025)

On September 23, 2025, ADM disclosed in an 8-K (Item 7.01, furnished rather than filed) that it signed a definitive agreement with Alltech to form a North American animal feed joint venture. The venture is part of ADM Nutrition's strategy to shift its Animal Nutrition business toward higher-growth, higher-margin specialty ingredients and to simplify the portfolio. Alltech will majority-own the joint venture and contribute its U.S. Hubbard Feeds and Canadian Masterfeeds businesses (18 U.S. and 15 Canadian feed mills). ADM will contribute its 11 U.S. complete feed mills and keep equal board representation. The key financial point for investors is deconsolidation. ADM expects to deconsolidate its complete feed business while retaining its proportionate share of specialty ingredient supply to the new venture. The companies expect to close and launch the joint venture in Q1 2026, and management states the transaction is not expected to have a material impact on 2025 financial results. The filing does not disclose purchase price, valuation, deal consideration, or the expected effect on future revenue, EBIT, or segment margins, so those remain open questions. From an investor standpoint, the transaction is a portfolio-simplification move rather than a near-term earnings event. Its significance will depend on the financial terms, the size of the deconsolidated revenue base, and whether ADM's remaining Nutrition segment achieves the higher margins it targets. Closing conditions, including regulatory approvals, remain a risk to the timeline.

Sep 23, 2025
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Aug 5, 2025)

ADM reported second-quarter 2025 results that were materially weaker than the prior year, though the company points to an expected improvement in the second half. GAAP earnings before income taxes were $279 million (down 53%), and GAAP diluted EPS was $0.45 (down 54%). Adjusted EPS was $0.93 (down 10%), and total segment operating profit was $830 million (down 10%). The decline was concentrated in Ag Services & Oilseeds, where segment operating profit fell 17% to $379 million, driven by a 75% drop in Crushing profit amid softer vegetable oil demand from biofuel and trade policy uncertainty. Carbohydrate Solutions fell 6% and Nutrition rose 5%. Year-to-date, adjusted EPS was $1.63 (down 35%) and GAAP EPS was $1.06 (down 56%). The GAAP-to-adjusted gap in the quarter was largely driven by $323 million of pretax impairment and restructuring charges tied to portfolio optimization, partly offset by a $69 million gain on contract termination. Management tightened full-year 2025 adjusted EPS guidance to approximately $4.00 per share, which implies a meaningful second-half recovery given the first-half adjusted EPS of $1.63. The company attributes this to recently improved margins, which it expects to benefit mainly the fourth quarter and beyond, following clarity on Renewable Volume Obligations (RVO) biofuel policy. Management also noted that less of its third-quarter order book is open to benefit from those margins. Operating cash flow was strong at $4.0 billion year-to-date, although this was largely driven by a $2.7 billion working capital release; cash flow before working capital was $1.2 billion. The company also reported remediation of a previously identified material weakness related to segment disclosures.

Aug 5, 2025
10-Q

Archer-Daniels-Midland Quarterly Report for Q2 Ended Jun 30, 2025

Archer-Daniels-Midland Co. (ADM) reported a decrease in earnings before income taxes to $279 million for the three months ended June 30, 2025, down from $596 million in the prior year period. This decline was primarily driven by significant asset impairment, exit, and restructuring costs amounting to $137 million, associated with portfolio optimization initiatives and a revised investment strategy. Revenues also saw a decline, falling by $1.1 billion to $21.2 billion, largely due to lower sales prices across key segments. Despite the top-line and bottom-line decreases, ADM's operational performance within its core segments showed mixed results. The Ag Services and Oilseeds segment experienced a notable decline in operating profit due to market pressures from increased global supplies and trade policy uncertainties. Conversely, the Nutrition segment demonstrated growth in operating profit, driven by strong performance in its Flavors and Animal Nutrition subsegments. The company's strategic initiatives, including targeted cost savings and portfolio simplification, are underway, with the recent acquisition of Vandamme Hugaria Kft in Hungary. ADM continues to maintain a strong liquidity position with significant unused lines of credit.

Aug 5, 2025
8-K

Archer-Daniels-Midland 8-K Report, Shareholder Vote Results (May 14, 2025)

Archer-Daniels-Midland Company (ADM) has filed an 8-K detailing the results of its 2025 Annual Meeting of Stockholders held on May 8, 2025. The filing indicates strong shareholder support for the company's slate of directors, with all nominees being elected with substantial 'For' votes. Additionally, shareholders approved, on an advisory basis, the compensation of the company's named executive officers, signaling confidence in the current executive pay structure. The company also secured shareholder ratification for the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2025. This decision suggests continued trust in the firm's audit services. However, a shareholder proposal seeking to remove the one-year holding period requirement to call a special stockholder meeting did not pass, indicating that the current provisions for calling special meetings will remain in place.

May 14, 2025
10-Q

Archer-Daniels-Midland Quarterly Report for Q1 Ended Mar 31, 2025

Archer-Daniels-Midland Co. (ADM) reported a notable decrease in net earnings for the first quarter of 2025 compared to the same period in the prior year, with net earnings attributable to the company falling to $295 million from $729 million. This decline is primarily driven by lower pricing and execution margins across its segments, particularly in Ag Services and Oilseeds, as well as reduced equity in earnings from unconsolidated affiliates. Revenues also saw a significant decrease of $1.7 billion, largely due to lower sales prices across all major segments, though this was partially offset by higher sales volumes in some areas. Despite the top-line and bottom-line pressures, the company continues to focus on its strategic priorities, including cost management, portfolio simplification, and targeted growth investments. The company also announced a restructuring program expected to deliver significant cost savings. Key financial developments include a substantial drop in segment operating profit, especially within Ag Services and Oilseeds, reflecting market headwinds such as increased global supplies, higher ending stocks-to-use ratios, and trade policy uncertainties. The Carbohydrate Solutions segment experienced a slight revenue decrease, while the Nutrition segment saw a modest increase in operating profit. Investors should note the ongoing investigations by the SEC and DOJ related to intersegment sales, and a previously disclosed material weakness in internal controls related to segment disclosures, although remediation efforts are underway.

May 6, 2025
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (May 6, 2025)

ADM reported first-quarter 2025 results on May 6, 2025 that were weak year over year but in line with management's outlook and market expectations. GAAP earnings before income taxes fell 60% to $353 million and diluted GAAP EPS fell 57% to $0.61. Adjusted EPS fell 52% to $0.70, and total segment operating profit fell 38% to $747 million. The decline was driven mainly by Ag Services & Oilseeds (AS&O), where segment operating profit dropped 52% to $412 million. Crushing fell 85% on lower margins from industry capacity additions, competing Argentine meal exports, higher manufacturing costs, and biofuel and trade policy uncertainty. Ag Services fell 31% on lower volumes and margins tied to tariff and trade uncertainty. Carbohydrate Solutions was roughly flat at $240 million (down 3%), and Nutrition grew 13% to $95 million, with Animal Nutrition up 150%. Cash flow was a notable negative. Operating cash flow was $(342) million, driven by a $(781) million working capital outflow. Cash flow from operations before working capital was $439 million. Net debt rose, with short-term debt up to $2.77 billion from $1.73 billion a year earlier, and shareholders' equity declined to $22.1 billion. Diluted share count fell to 483 million from 514 million, reflecting prior share repurchases that partly cushion the per-share decline. Management reaffirmed full-year 2025 adjusted EPS guidance of $4.00 to $4.75 but said ADM now expects to land at the lower end of the range given current market conditions. For investors, the key issues are whether the self-help agenda (operational improvements, cost savings, portfolio simplification) can offset weak crush margins and trade-policy uncertainty, and whether the working capital build reverses in coming quarters.

May 6, 2025
10-K

Archer-Daniels-Midland Annual Report, Year Ended Dec 31, 2024

Archer-Daniels-Midland Company (ADM) reported a significant decrease in earnings before income taxes for the year ended December 31, 2024, down 47% to $2.3 billion, primarily driven by lower pricing and execution margins, and a substantial impairment charge of $461 million related to its investment in Wilmar. Total segment operating profit also saw a decrease of 28%, mainly due to weaker performance in the Ag Services and Oilseeds and Nutrition segments. The company is actively managing its exposure to commodity price fluctuations and has completed several strategic acquisitions in the Nutrition segment, including Revela Foods, FDL, PT Trouw Nutrition Indonesia, and Totally Natural Solutions Ltd., aiming to bolster its presence in high-growth markets. Despite a challenging year impacted by macroeconomic headwinds, inflation, and specific segment pressures like depressed vegetable oil demand and uncertainty around tax credits, ADM maintained its focus on its strategic pillars of Productivity, Innovation, and Culture. The company also continues to invest in sustainability initiatives, including regenerative agriculture practices with a goal to enroll five million acres by the end of 2025. However, ADM identified a material weakness in its internal control over financial reporting related to segment disclosures, which is being addressed through remediation efforts. The company also faces ongoing investigations from the SEC and DOJ concerning intersegment sales, the outcomes of which remain uncertain.

Feb 20, 2025
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Feb 4, 2025)

ADM reported fourth-quarter and full-year 2024 results on February 4, 2025, showing a sharp earnings decline. Full-year GAAP net earnings attributable to ADM were $1.8 billion (EPS $3.65, down 43%), while adjusted EPS was $4.74 (down 32%). Total segment operating profit fell 28% to $4.2 billion, with the Ag Services & Oilseeds segment down 40% to $2.4 billion, driven by weaker crush margins and a sharp drop in Refined Products and Other margins amid biofuel and trade policy uncertainty. Carbohydrate Solutions was flat at $1.4 billion, and Nutrition declined 10% to $386 million. Fourth-quarter adjusted EPS of $1.14 fell 16% year over year, though GAAP EPS rose 10% on a lower share count and a favorable mix of specified items. Operating cash flow fell to $2.8 billion from $4.5 billion, and the full-year figures were also affected by roughly $231 million of Decatur East and West insurance settlements. Management guided 2025 adjusted EPS to $4.00 to $4.75, citing weaker market fundamentals and ongoing biofuel and trade policy uncertainty. To address this, ADM announced targeted actions to deliver $500 to $750 million in cost savings over three to five years, including a targeted reduction of roughly 600 to 700 roles globally in 2025. The company also raised its quarterly dividend 2% to $0.51 per share, marking its 93rd consecutive year of uninterrupted dividends. Investors will be watching whether the cost program offsets soft crush and biofuel margins, and whether the company can restore cash generation while maintaining its share repurchase and dividend commitments.

Feb 4, 2025
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (Jan 29, 2025)

On January 29, 2025, ADM announced the appointment of Carrie Nichol as Vice President and Chief Accounting Officer, effective March 1, 2025. Nichol joins from Cargill, where she was Senior Vice President, Chief Accounting Officer and Global Process Leader since June 2024, and previously served as Vice President, Finance and Controller. She also held the Chief Accounting Officer role at Zimmer Biomet and began her career at KPMG. She will report to CFO Monish Patolawala and oversee external and management accounting and reporting, internal controls, and insurance and risk management. She succeeds Molly Strader Fruit, who moves to Vice President, Total Rewards and HR Operations, and will assist in the transition. The filing is primarily a leadership-continuity event rather than a financial disclosure. No financial results, guidance, or operating metrics are included, and the 8-K does not indicate any accounting issues, restatements, or control weaknesses. For investors, the key governance question is continuity in the finance function following a change in the CAO role, which is mitigated by a planned overlap period and the appointment of an experienced external hire with public-company and large-cap accounting backgrounds. Compensation disclosed for Nichol includes a $550,000 base salary, a $500,000 target annual bonus, and an approximately $1.315 million annual equity award (60% PSUs, 40% RSUs). The package also includes make-whole payments totaling roughly $1.381 million, subject to clawback if she leaves voluntarily within two years, and an approximately $980,000 RSU make-whole award to replace forfeited equity from Cargill. These amounts are modest relative to ADM's executive pay structure and reflect typical make-whole arrangements for senior hires.

Jan 29, 2025
8-K

Archer-Daniels-Midland 8-K Report, Regulation FD Disclosure (Dec 2, 2024)

ADM's 8-K (Item 7.01, dated December 2, 2024) furnishes the presentation for its third-quarter 2024 earnings call on December 3, 2024. Results were weak. Q3 adjusted EPS was $1.09, down about 33% from $1.63, and GAAP EPS fell to $0.04 from $1.52. Total segment operating profit was $1.04 billion, down 28%. Year-to-date adjusted EPS was $3.61, down 36%, and YTD total segment operating profit was $3.2 billion, down 32%. Management attributed the decline mainly to lower margins and price in Ag Services & Oilseeds and Carbohydrate Solutions, partly offset by higher volumes. Ongoing issues include the unplanned downtime at Decatur East, which is not expected to resume until Q1 2025, along with insurance-related charges and claims payouts. The most consequential item for investors is the guidance cut. FY2024 adjusted EPS guidance was lowered to $4.50–$5.00 from $5.25–$6.25, implying a sharp drop from FY2023's $6.98. Management expects significantly lower biodiesel and refining margins in Q4 and cites uncertainty from the transition to the producer tax credit. Other guidance was largely maintained: capex of about $1.5 billion, a corporate net interest expense range of $475–$525 million, and an adjusted net debt to adjusted EBITDA ratio of 1.5x–2.0x, versus 1.9x at quarter-end. Management also announced a "productivity agenda" focused on cost savings, capital discipline, portfolio optimization, and returning cash. Cash from operations before working capital fell 39% YTD to $2.3 billion, while ADM returned $3.1 billion to shareholders through dividends and buybacks in the period. The filing also discloses that prior-year segment figures were restated for error corrections, and that certain items (Other Business, specified items) are now shown as reconciling items rather than inside total segment operating profit. This affects comparability with previously reported figures. Investors should weigh the earnings decline and guidance reduction against the company's ongoing restatement-related changes and the operational and insurance-related uncertainties that remain.

Dec 2, 2024
10-K

Archer-Daniels-Midland Annual Report (Amendment), Year Ended Dec 31, 2023

Archer-Daniels-Midland Company (ADM) has filed an amendment to its 2023 10-K, primarily to restate its consolidated financial statements due to identified issues with intersegment sales accounting within its Nutrition reporting segment. While the core financial results for revenue and profit are not impacted at the consolidated level, the restatement affects segment-specific historical financial information. The company also disclosed a material weakness in internal controls over financial reporting related to these segment disclosures, stemming from inadequate controls in recording intersegment sales at amounts approximating market. This led to the placement of the former CFO on administrative leave and subsequent departure, and ongoing investigations by the SEC and DOJ. Despite these accounting issues, ADM continues to operate as a global leader in agricultural supply chain management and nutrition. The company highlights its strategic focus on productivity, innovation, and culture, with ongoing investments in regenerative agriculture and sustainable solutions. Its diversified business segments—Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition—remain key drivers of its operations, with the company actively managing market volatilities and investing in growth initiatives. Investors should remain aware of the ongoing investigations and the remediation efforts being undertaken to strengthen internal controls.

Nov 18, 2024
10-Q

Archer-Daniels-Midland Quarterly Report (Amendment) for Q2 Ended Jun 30, 2024

Archer-Daniels-Midland Co. (ADM) reported a decrease in revenues and net earnings for the three and six months ended June 30, 2024, compared to the same periods in the prior year. This decline is primarily attributed to lower pricing and execution margins across its Ag Services and Oilseeds segment, as well as softer demand in certain Nutrition product categories. Despite the revenue decline, ADM made strategic acquisitions in the Nutrition segment, adding capabilities and expanding its portfolio. The company also continued its share repurchase program, demonstrating a commitment to returning capital to shareholders. ADM is actively working to remediate a previously identified material weakness in its internal control over financial reporting related to intersegment sales, with an ongoing focus on strengthening these controls.

Nov 18, 2024
10-Q

Archer-Daniels-Midland Quarterly Report (Amendment) for Q1 Ended Mar 31, 2024

Archer-Daniels-Midland Co. (ADM) reported a decrease in net earnings attributable to controlling interests for the first quarter of 2024 to $729 million, or $1.42 per diluted share, compared to $1,170 million, or $2.12 per diluted share, in the same period of 2023. This decline was primarily driven by lower revenues across its Ag Services and Oilseeds, and Carbohydrate Solutions segments, influenced by reduced sales prices and volumes, alongside softer demand in certain Nutrition product categories. Despite the overall earnings decline, ADM completed several strategic acquisitions in its Nutrition segment during the quarter, adding capabilities in dairy flavor ingredients and animal nutrition solutions. The company also continued its share repurchase program, authorizing a significant accelerated share repurchase transaction. Management highlights a focus on productivity and innovation to navigate market challenges, including headwinds in the agriculture cycle and softer demand in some consumer segments.

Nov 18, 2024
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Nov 18, 2024)

ADM reported third-quarter 2024 results that were largely in line with preliminary figures released earlier, and filed its Q3 10-Q alongside restated financial statements for fiscal 2023 and the first two quarters of 2024. GAAP results were sharply weaker: Q3 earnings before income taxes fell 90% year over year to $108 million, and GAAP diluted EPS was $0.04, versus $1.52 a year earlier. The decline was driven mainly by a non-cash $461 million impairment on ADM's Wilmar equity investment, which was deemed other-than-temporary given the decline in its Singapore Exchange trading price. Excluding specified items, adjusted EPS was $1.09 (down 33%) and total segment operating profit was $1,037 million (down 28%). The core drag came from Ag Services & Oilseeds, where segment profit fell 43% on lower South American origination margins, weaker Refined Products & Other margins (driven by imported used cooking oil and biodiesel pressure), and mark-to-market timing swings. Carbohydrate Solutions was roughly flat, with Starches & Sweeteners up 13% offset by a loss at Vantage Corn Processors, while Nutrition fell 19% on Decatur East downtime and weaker texturants pricing. Management affirmed full-year 2024 adjusted EPS guidance of $4.50 to $5.00, implying a sharp fourth-quarter step-up from the year-to-date run-rate of $3.61. The company said it expects softer market conditions into 2025, and it flagged that further Wilmar-related charges are possible. It also noted that Q3 benefited from roughly $96 million of insurance settlements related to the 2023 Decatur incidents, which are non-recurring in nature. The restatement involved intersegment transactions and, per the company, had no effect on consolidated balance sheet, earnings, or cash flows. Investors should still weigh the governance and internal-control remediation that the restatement signals, along with the company's continued share repurchases ($2.3 billion year-to-date) and rising short-term debt ($1.7 billion versus $116 million a year earlier).

Nov 18, 2024
10-Q

Archer-Daniels-Midland Quarterly Report for Q3 Ended Sep 30, 2024

Archer-Daniels-Midland Co. (ADM) reported a significant decrease in net earnings for the third quarter of fiscal year 2024 compared to the prior year, primarily driven by a substantial $461 million impairment charge related to its investment in Wilmar. This charge significantly impacted the Ag Services and Oilseeds segment and led to a sharp increase in the effective tax rate. While revenues saw a decline due to lower sales prices across segments, this was partially offset by higher sales volumes. Despite the quarterly earnings pressure, ADM demonstrated resilience in cash flow generation, with operating cash flow increasing year-over-year. The company also continued its strategic acquisitions within the Nutrition segment and repurchased a significant amount of its own stock. However, investors should note the ongoing investigations by the SEC and DOJ concerning intersegment sales, which have led to a material weakness in internal controls over financial reporting. The company is actively implementing remediation measures.

Nov 18, 2024
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (Nov 6, 2024)

Archer-Daniels-Midland Co (ADM) filed an 8-K on November 6, 2024 to report a board change. Effective November 1, 2024, the Board increased its size from 11 to 12 directors and appointed David R. McAtee II, Senior Executive Vice President and General Counsel of AT&T Inc., as an independent director to fill the newly created seat. He will serve until the next annual meeting of stockholders and has been placed on the Nominating and Corporate Governance Committee and the Compensation and Succession Committee. The filing states there are no arrangements or understandings between Mr. McAtee and other persons relating to his election, and he has no related person transactions requiring disclosure under Item 404(a) of Regulation S-K. His director compensation will follow the policies for ADM's other non-employee directors, as described in the company's 2024 proxy statement filed April 10, 2024. No financial results, guidance, or material financial metrics are disclosed in this filing. For investors, this is a routine governance event rather than a material financial development. The addition of a seasoned general counsel with experience in governance, M&A, regulation, and data security may strengthen board oversight, and his placement on the compensation and governance committees gives him a direct role in those areas. The filing's direct impact on ADM's valuation or operations appears limited.

Nov 6, 2024
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Nov 5, 2024)

ADM's November 4, 2024 8-K (Item 2.02) furnishes a press release with preliminary, unaudited third-quarter 2024 results and announces two significant developments: a restatement of the FY2023 Form 10-K and the Q1 and Q2 2024 Form 10-Qs, and a postponed Q3 earnings call. Preliminary GAAP net earnings were $18 million ($0.04 per diluted share), versus $821 million ($1.52) a year earlier, driven by a $461 million non-cash impairment of the Wilmar equity investment deemed other-than-temporary. Adjusted net earnings were $530 million ($1.09 per share), down from $880 million ($1.63). Trailing four-quarter ROIC was 6.6% (adjusted 8.8%), and adjusted EBITDA for the trailing four quarters was $4.706 billion. Year-to-date operating cash flow was $2.468 billion, but cash flow from operations before working capital fell to $2.341 billion from $3.804 billion. Segment performance was mixed. Carbohydrate Solutions was the bright spot, with Starches & Sweeteners up 13%, though segment operating profit still fell 3% in total. Ag Services and Oilseeds dropped 43% to $480 million on weaker South American origination, lower refining and biodiesel margins, and mark-to-market timing swings. Nutrition fell 19%, hurt by unplanned downtime at Decatur East. Much of the quarter's reported profit was cushioned by roughly $96 million in Decatur insurance settlements, which investors should treat as non-recurring. Management lowered full-year 2024 adjusted EPS guidance to $4.50-$5.00. The most consequential item for investors is governance and controls. The company identified new misclassified intersegment transactions during Q3 testing of its material weakness remediation, and it is restating segment disclosures after dialogue with the SEC. Management states the restatement should not materially affect consolidated earnings, balance sheet, or cash flow, but the postponed earnings call and the unresolved timeline for the amended filings add uncertainty. The company also warned that further Wilmar impairments are possible.

Nov 5, 2024
8-K

Archer-Daniels-Midland 8-K Report, Financial Restatement (Nov 5, 2024)

Archer-Daniels-Midland Co. (ADM) has filed an 8-K report announcing that its previously issued financial statements for fiscal year 2023 and the first and second quarters of 2024 will be restated. This restatement is necessary due to identified errors in segment information disclosures, specifically concerning intersegment sales amounts and classifications. The company is revising its FY2023 Form 10-K and its Q1 and Q2 2024 Form 10-Qs to correct these misstatements. Importantly, ADM states that the restatements are not expected to have a material impact on the company's overall financial results, such as earnings, balance sheets, or cash flows. The errors identified primarily relate to the accuracy and classification of intersegment sales within its Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition segments. In connection with these errors, ADM has also identified and is actively remediating a material weakness in its internal control over financial reporting related to intersegment sales accounting.

Nov 5, 2024
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Jul 30, 2024)

ADM's second-quarter 2024 results were weak on a year-over-year basis but in line with the company's messaging of a difficult margin environment. GAAP earnings before taxes fell 47% to $596 million and GAAP diluted EPS fell 42% to $0.98. Adjusted segment operating profit declined 37% to $1,021 million, and adjusted EPS was $1.03, down 46% from the prior year. The primary driver was lower pricing and execution margins, particularly in Ag Services & Oilseeds (AS&O), where segment operating profit fell 56% to $459 million on weaker crush margins, lower origination margins as South American supply shifted export competitiveness, and a roughly $180 million year-over-year swing in negative mark-to-market timing in Refined Products & Other. Share repurchases, which contributed $0.10 per share in the quarter and $0.21 per share in the first half, partially cushioned the earnings decline. The underlying segment picture was mixed. Carbohydrate Solutions grew 12% to $357 million on strong starches and sweeteners and ethanol export demand, and Nutrition showed sequential improvement in the quarter although it was still down 36% year over year, weighed on by unplanned downtime at Decatur East. Operating cash flow for the first half was $1.17 billion, but the company spent $1.6 billion on investing activities, including $936 million on acquisitions, and $2.3 billion on share repurchases. Short-term debt rose to $2.3 billion from $125 million a year earlier, and cash fell to $764 million, so balance sheet flexibility is worth monitoring. Management affirmed full-year 2024 adjusted EPS guidance of $5.25 to $6.25 and pointed to improved crush and ethanol margins and operational excellence efforts as reasons for confidence in the second half. The guidance range is wide, and the company did not provide a GAAP EPS forecast because it cannot reliably predict impairment, restructuring, and other charges. Investors should weigh whether the expected second-half recovery materializes given the continued pressure in origination and crush.

Jul 30, 2024
10-Q

Archer-Daniels-Midland Quarterly Report for Q2 Ended Jun 30, 2024

Archer-Daniels-Midland Co. (ADM) reported a decrease in net earnings attributable to controlling interests for the three months ended June 30, 2024, to $486 million ($0.98 per share), down from $927 million ($1.70 per share) in the same period last year. For the six months ended June 30, 2024, net earnings fell to $1.215 billion ($2.41 per share) from $2.097 billion ($3.82 per share) in the prior year period. This decline was primarily driven by lower pricing and execution margins across its Ag Services and Oilseeds segment, as well as softer demand in certain Nutrition product categories due to shifts in consumer spending and inflationary pressures. Despite the revenue and earnings decline, ADM's liquidity remains strong, with $8.6 billion in total available liquidity as of June 30, 2024, comprising cash and cash equivalents and unused lines of credit. The company also continued its aggressive share repurchase program, buying back approximately $2.3 billion in the first six months of the year. ADM is actively managing its portfolio through strategic acquisitions to enhance its Nutrition businesses and is focused on its three strategic pillars: Productivity, Innovation, and Culture to drive future growth and efficiency.

Jul 30, 2024
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (Jul 10, 2024)

On July 10, 2024, ADM announced the appointment of Monish Patolawala as Executive Vice President and Chief Financial Officer, effective August 1, 2024. He succeeds Ismael Roig, who has served as Interim CFO since January 21, 2024, and who will continue as President of EMEA and President of Animal Nutrition. Patolawala most recently served as President and CFO of 3M, and previously held CFO roles at GE Healthcare and GE Transportation. He also sits on the Biogen Inc. board. The filing is primarily a leadership transition disclosure rather than a financial-results update, so it contains no new earnings, guidance, or balance sheet information. The filing's most investor-relevant element is the compensation package, which signals the Board's intent to attract an experienced external CFO. Base salary is $1,425,000, with a target annual bonus of $1,923,750 and an annual equity award of about $6.95 million (60% PSUs, 40% RSUs). To offset awards forfeited from 3M, the company is providing a one-time $1.4 million cash make-whole payable in January 2025 and about $10 million in RSUs vesting over 18 months. The new CFO will oversee Global Finance and Accounting, Global Business Services, Global Technology, and Enterprise Strategy, so the appointment ends a period of interim finance leadership. For investors, the key takeaways are continuity and stability in finance leadership after roughly six months under an interim CFO, and an incoming executive whose background centers on operational discipline and transformation. Because the release frames the appointment around productivity, operational excellence, and shareholder value, investors may look for follow-through on those priorities in upcoming earnings calls and filings. The filing does not describe any change in ADM's financial outlook.

Jul 10, 2024
8-K

Archer-Daniels-Midland 8-K Report, Shareholder Vote Results (May 29, 2024)

Archer-Daniels-Midland Company (ADM) has filed an 8-K report detailing the outcomes of its 2024 Annual Meeting of Stockholders held on May 23, 2024. The meeting saw routine shareholder matters addressed, with a strong affirmation of the company's current leadership and strategic direction. All director nominees presented were elected by a significant majority, indicating shareholder confidence in the current board's governance. Additionally, the compensation of named executive officers received advisory approval, and the appointment of Ernst & Young LLP as the independent auditor for fiscal year 2024 was ratified, underscoring shareholder support for established audit practices. Notably, a shareholder proposal advocating for an Independent Board Chairman did not pass, receiving a majority of 'Against' votes. This outcome suggests that the current board structure and leadership model are favored by the majority of ADM's voting shareholders. Overall, the meeting's results reflect a stable shareholder environment, with broad support for the company's existing governance and auditing arrangements, while also signaling a preference against changes to the board's leadership structure at this time.

May 29, 2024
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Apr 30, 2024)

ADM reported first-quarter 2024 results that fell sharply year over year but were in line with management's expectations for a challenging market. GAAP EPS was $1.42, down 33% from $2.12, and adjusted EPS was $1.46, down 30% from $2.09. Adjusted segment operating profit was $1,317 million, down 24%, driven primarily by Ag Services & Oilseeds (down 29%), where lower crush and origination margins, a stabilization of trade flows that reduced Global Trade and risk management gains, and a sharp drop in mark-to-market timing benefits weighed on results. Nutrition (down 39%) and Carbohydrate Solutions (down 11%) also declined, while the Other segment rose 25%. Management affirmed full-year 2024 adjusted EPS guidance of $5.25 to $6.25, a wide range that signals continued uncertainty. Cash flow and balance sheet data show a mixed picture. Operating cash flow turned positive at $700 million versus a $1,610 million outflow a year earlier, largely because of smaller working capital build. However, the company spent $915 million on acquisitions, $1,327 million on share repurchases (including the accelerated share repurchase program), and $257 million on dividends, funded in part by a $1,619 million increase in net borrowings. Short-term debt, long-term debt, and shareholders' equity all trended in ways that warrant monitoring, and cash fell to $830 million. Trailing four-quarter adjusted ROIC was 11.2%, and adjusted EBITDA was $5.74 billion. For investors, the key questions are whether margins in crush and origination stabilize as management expects, whether the Nutrition segment recovers from the Decatur East downtime and normalizing texturants market, and whether the company can deliver on guidance while funding both acquisitions and substantial buybacks with rising debt. The filing itself is a routine Item 2.02 disclosure furnishing the earnings press release as Exhibit 99.1, and the non-GAAP measures are reconciled within that release.

Apr 30, 2024
10-Q

Archer-Daniels-Midland Quarterly Report for Q1 Ended Mar 31, 2024

Archer-Daniels-Midland Company (ADM) reported its first-quarter 2024 financial results, showing a decrease in net earnings attributable to controlling interests to $729 million from $1.17 billion in the prior year's comparable period. This decline was primarily driven by lower commodity prices and volumes across its Ag Services and Oilseeds, and Carbohydrate Solutions segments. Despite the top-line revenue decrease of $2.2 billion, ADM maintained solid operational execution in its Nutrition segment, which saw comparable revenues year-over-year, and demonstrated robust cash generation from operations. The company completed significant acquisitions in the quarter, adding capabilities to its Nutrition business. ADM also continued its capital return program, repurchasing $1.3 billion in stock and paying $0.3 billion in dividends. Management highlighted the challenging market conditions, particularly in the agriculture cycle, but remains focused on its strategic pillars of Productivity, Innovation, and Culture to drive future growth. Investors should note the ongoing SEC investigation into intersegment sales, which has led to a material weakness in internal controls over financial reporting, though this has not impacted consolidated financial statements.

Apr 30, 2024
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (Apr 22, 2024)

This 8-K filing from Archer-Daniels-Midland Co. (ADM) announces a Transition Agreement with Vikram Luthar, the Executive Vice President and Chief Financial Officer. Mr. Luthar will resign from his executive role effective September 30, 2024, though this date may be earlier if mutually agreed. During this transition period, he will serve as a non-executive employee, providing transitional support. This agreement outlines Mr. Luthar's compensation and benefits during and after his transition. He will receive his 2023 performance incentive and earned shares from a 2021 award, consistent with other executives. He will continue to receive his base salary and benefits during the transition. Post-resignation, he is eligible for a prorated 2024 performance incentive (if employed through July 1, 2024) and retirement treatment for outstanding equity awards, meeting age and service requirements.

Apr 22, 2024
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (Mar 20, 2024)

This 8-K filing from Archer-Daniels-Midland Co (ADM) primarily details the compensation arrangements for Ismael Roig during his tenure as Interim Chief Financial Officer. Appointed on January 21, 2024, Mr. Roig will receive a monthly cash stipend of $35,000, in addition to his base salary, for his service in this interim role. This stipend will be pro-rated for any partial months served. Furthermore, Mr. Roig has been granted restricted stock units (RSUs) valued at $1,000,000 as of March 18, 2024. These RSUs are subject to a one-year vesting period, contingent on his continued service. The filing also outlines specific conditions regarding forfeiture or continued vesting of these RSUs in the event of Mr. Roig's retirement, particularly in relation to the appointment of a permanent CFO. This information is crucial for investors to understand the financial implications and incentive structures associated with the company's interim CFO leadership.

Mar 20, 2024
10-K

Archer-Daniels-Midland Annual Report, Year Ended Dec 31, 2023

Archer-Daniels-Midland Company (ADM) reported its 2023 full-year results, showcasing resilience across its diverse agribusiness segments despite a challenging market environment. The company's strategic focus on Productivity, Innovation, and Culture continues to guide its operations, aiming to optimize costs, drive growth through sustainable solutions, and foster an agile organization. While facing headwinds such as softer demand in certain consumer-facing nutrition categories and inflationary pressures, ADM demonstrated strong performance in its Ag Services and Oilseeds segment, particularly driven by record soybean production in Brazil and demand for sustainable biofuels. The company is actively managing its operational and financial risks, including navigating geopolitical uncertainties and implementing strategies to mitigate the impact of climate change. ADM is also addressing a previously disclosed internal investigation into certain accounting practices related to intersegment sales. While this investigation has led to the identification of a material weakness in internal controls and government inquiries, the company is cooperating fully and implementing remediation plans. The impact of these adjustments on consolidated financial statements was deemed immaterial, but segment-specific financial information has been revised. Looking ahead, ADM remains committed to its sustainability goals and innovation pipeline, investing in new technologies and partnerships to deliver value for its stakeholders. The company's strong liquidity position and ongoing share repurchase program underscore its financial health and commitment to returning capital to shareholders, even as it navigates regulatory scrutiny and market dynamics.

Mar 12, 2024
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Mar 12, 2024)

ADM reported fourth-quarter and full-year 2023 results on March 12, 2024, and the picture is one of earnings compression from a strong 2022 base. Full-year GAAP EPS was $6.43 (down 17%) and adjusted EPS was $6.98 (down 11%). Adjusted segment operating profit was $6,244 million, down 6%. Q4 was weaker: adjusted EPS of $1.36 fell 30% and adjusted segment operating profit dropped 16%, driven by lower crush and origination margins, a Nutrition loss, and unplanned downtime at the Decatur complex. Ag Services & Oilseeds, the core earnings engine, fell 8% for the year, and equity earnings from Wilmar dropped about 45%. Carbohydrate Solutions was roughly flat, Nutrition fell 36%, and Other rose 125%, helped by Captive Insurance and higher interest income at ADM Investor Services. The forward-looking guidance is the main investor concern. ADM expects 2024 adjusted EPS of $5.25 to $6.25, which is down about 18% at the midpoint, reflecting moderating crush margins (guided to $35 to $60/MT), higher costs, and a slightly lower Carbohydrate Solutions outlook. Nutrition is expected to grow operating income. Management is leaning on capital returns to support per-share value: it authorized an additional $2 billion in buybacks, including about $1 billion through an accelerated share repurchase, on top of $2.67 billion repurchased in 2023. Cash from operations was strong at $4.46 billion, and Adjusted ROIC was 12.2%. The filing also notes that an internal investigation into intersegment transactions was substantially complete, with details to come in the 10-K. That disclosure is a governance item investors will want to track.

Mar 12, 2024
8-K

Archer-Daniels-Midland 8-K Report, Regulation FD Disclosure (Jan 26, 2024)

On January 26, 2024, Archer-Daniels-Midland (ADM) furnished an 8-K under Regulation FD containing an internal message from Chair and CEO Juan Luciano to employees. The message confirms that ADM is conducting an investigation into intersegment sales, meaning transfers of goods and the related accounting between its business segments. Management says this investigation is why the closing of Q4 and full-year 2023 financial results is taking longer than usual, and it states that these sales do not materially affect overall results. The filing itself contains no quantified financial impact, no detail on the scope of the review, and no regulatory or legal specifics, so investors should treat the company's characterization as management's position rather than an audited finding. The message also gives several preliminary indicators. ADM expects to report its second-best result in company history, with adjusted earnings per share above $6.90 for 2023. The Board declared a quarterly cash dividend of $0.50 per share, consistent with the company's stated dividend growth commitment and its record of more than 92 years of dividends. Management expects Q4 2023 adjusted net debt to adjusted EBITDA leverage to remain at levels similar to Q3 2023, which it describes as healthy. The filing's forward-looking statements explicitly flag risks including the timing and results of the investigations, possible changes to expected 2023 results, and the risk of failing to file 2023 reports with the SEC on time. For investors, the central issue is timing and disclosure risk rather than a confirmed earnings problem. The delayed close raises the possibility of a late 10-K filing, restatement, or changes to segment reporting, all of which could affect confidence in the numbers. Investors should watch for the timing of the Q4 earnings release and 10-K, any changes to previously reported segment results (particularly Ag Services & Oilseeds and Carbohydrate Solutions), and any further regulatory or legal developments.

Jan 26, 2024
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Jan 22, 2024)

On January 21, 2024, ADM disclosed that its Board placed Chief Financial Officer and SVP Vikram Luthar on administrative leave, pending an Audit Committee-overseen investigation by outside counsel into accounting practices and procedures in the Nutrition reporting segment, including certain intersegment transactions. The probe began after ADM received a voluntary document request from the SEC, and the company says it is cooperating. Ismael Roig, a 20-year ADM veteran who most recently led EMEA and Animal Nutrition, was appointed Interim CFO. The company also delayed its Q4 and full-year 2023 earnings release, conference call, and Form 10-K filing from their historical schedule, with an update on timing to follow. On the financial side, ADM now expects full-year 2023 adjusted EPS above $6.90, subject to completion of year-end close and internal controls. Operating profit for the Ag Services & Oilseeds (AS&O) and Carbohydrate Solutions segments is expected in line with October 24, 2023 guidance, but ADM withdrew all forward-looking outlook for the Nutrition segment. For investors, the central uncertainty is the scope and outcome of the investigation, the potential for restated or changed Nutrition results, the timing of the delayed 10-K, and the possibility of further SEC action. The company explicitly declined to forecast GAAP EPS, citing the difficulty of predicting impairments, charges, and legal or tax outcomes that could be material. Investors should treat the $6.90 figure as conditional and monitor the next filings and disclosures closely.

Jan 22, 2024
8-K

Archer-Daniels-Midland 8-K Report, Executive Changes (Nov 13, 2023)

ADM (NYSE: ADM) disclosed in this Form 8-K, filed November 13, 2023, a leadership change in its Nutrition business. Ian Pinner, previously Senior Vice President, Strategy and Innovation, was appointed Senior Vice President, President, Nutrition, and Chief Sales and Marketing Officer, effective November 10, 2023. He succeeds Vincent (Vince) Macciocchi, who is retiring effective December 31, 2023 and will support the transition through year-end. The filing is an executive transition rather than a financial event. No financial results, guidance, or transaction terms are disclosed. The filing is limited to Item 5.02 (officer departure and appointment) and Item 9.01 (exhibits), with the press release furnished as Exhibit 99.1. Because Nutrition is one of ADM's two core reporting segments and a major driver of its earnings, the choice of successor is the main item of interest for investors. Pinner brings a 24-year ADM career, including roles as chief strategy and innovation officer, chief growth officer, and regional and business-unit president. The company's stated rationale is continuity: his strategy, M&A, and growth-platform experience is positioned to support the ongoing growth of the Nutrition business. Macciocchi's year-end retirement and overlap period suggest an orderly handover, though investors may watch whether the new role's responsibilities change the company's strategic priorities.

Nov 13, 2023
8-K

Archer-Daniels-Midland 8-K Report, Financial Results (Oct 24, 2023)

ADM reported third-quarter 2023 results on October 24, 2023, with reported EPS of $1.52 (vs. $1.83 a year earlier) and adjusted EPS of $1.63 (vs. $1.86). Net earnings attributable to ADM were $821 million and adjusted net earnings were $880 million. Segment operating profit fell to $1.42 billion from $1.56 billion, driven almost entirely by a sharp decline in Ag Services & Oilseeds (down $227 million, mainly Crushing and Wilmar equity earnings), partly offset by a strong Carbohydrate Solutions quarter (up $151 million on ethanol, starches and sweeteners margins) and higher Refined Products and Other results. Nutrition declined on weak plant-based protein demand, the Decatur incident, and Pet Solutions challenges. Management raised its full-year earnings outlook, citing strong year-to-date performance and a constructive view for the remainder of 2023. Balance-sheet and cash-flow metrics were mixed. Year-to-date operating cash flow fell to $1.89 billion from $3.35 billion, largely due to working capital outflows of $1.91 billion, while capital expenditures rose to $1.06 billion. Cash and equivalents were $1.50 billion at quarter-end, and long-term debt was $8.2 billion, versus $8.6 billion a year earlier. Trailing four-quarter adjusted ROIC was 13.2%, and trailing adjusted EBITDA was $6.57 billion. Q3 results included a $0.10 per share net charge for impairments and restructuring and a $62 million year-to-date contingency provision related to import duties. For investors, the key tension is between a shrinking crushing and Wilmar contribution and resilient ethanol and flavors performance, alongside a higher full-year guidance that depends on management's view of the remainder of the year. The filing is a press-release furnishing under Item 2.02 and is not deemed filed under Section 18 of the Exchange Act.

Oct 24, 2023
10-Q

Archer-Daniels-Midland Quarterly Report for Q3 Ended Sep 30, 2023

Archer-Daniels-Midland Co. (ADM) reported revenues of $21.7 billion for the three months ended September 30, 2023, a decrease from $24.7 billion in the prior year period. Net earnings attributable to controlling interests were $821 million ($1.52 per diluted share), down from $1.03 billion ($1.83 per diluted share) in the same period last year. This decline was primarily driven by lower segment operating profit across Ag Services and Oilseeds, and Nutrition, influenced by factors such as reduced sales prices for key commodities and softer demand in certain food and beverage categories. Despite the year-over-year decline in earnings, ADM demonstrated resilience with stable gross profit and a continued focus on strategic initiatives. The company's Carbohydrate Solutions segment saw improved operating profit, and overall cash flow from operations remained substantial. ADM continues to invest in innovation and sustainability, exemplified by its regenerative agriculture program and new facility openings. The company maintains a strong liquidity position with significant unused credit facilities, supporting its ongoing capital allocation priorities including dividends and share repurchases.

Oct 24, 2023
10-Q

Archer-Daniels-Midland Quarterly Report (Amendment) for Q2 Ended Jun 30, 2023

Archer-Daniels-Midland Co. (ADM) reported net earnings attributable to controlling interests of $927 million ($1.70 diluted EPS) for the three months ended June 30, 2023, a decrease from $1,236 million ($2.18 diluted EPS) in the prior-year period. For the six months ended June 30, 2023, net earnings were $2,097 million ($3.82 diluted EPS), down from $2,290 million ($4.03 diluted EPS) in the same period of 2022. The decline in profitability was primarily driven by lower results in the Ag Services and Oilseeds segment, particularly in Crushing and Ag Services, along with a notable decrease in the Carbohydrate Solutions segment. Despite the year-over-year earnings decrease, ADM demonstrated resilience in its liquidity position. Cash provided by operating activities was $0.9 billion for the first six months of 2023, a significant improvement from a cash usage of $0.7 billion in the prior-year period. The company maintained a strong balance sheet with total assets of $55.5 billion and shareholders' equity of $25.0 billion as of June 30, 2023. ADM also returned capital to shareholders through share repurchases totaling $1.0 billion and dividends of $0.5 billion in the first six months of 2023, and has approximately $12.7 billion in total available liquidity.

Sep 11, 2023